Inhibitor refers to substance that can hinder the chemical reactions, biological reactions (including immune response) and biological activity. In present time, commonly used inhibitors include immunosuppressants and inhibitors. 1. Immunosuppressive agents: immunosuppressants system refers to drug that can reduce the immune response. It can selectively suppress certain steps of the immune response and immune cells. Immune response refers to the body’s response to a variety of pathogenic substances. Some reactions are favorable to the body and can enhance the body's resistance to disease; some have adverse effects on the body and can cause tissue damage or disorders of physiological functions (allergy). Therefore, patients suffering from allergic reactions being harmful to the body should be subject to the treatment of immunosuppressant to affect the related immune processes and reduce the immune response of the body. For the treatment of various autoimmune diseases and weakening the tissue incompatibility, it has been developed of a variety of immunosuppressive agents, some of which have been widely used in clinical practice. Commonly used immunosuppressants include glucocorticoids (prednisone, prednisolone, etc.), alkylating agents (nitric oxide mustard, cyclophosphamide, thiotepa, busulfan, etc.), and antimetabolites (6- mercaptopurine, azathioprine, methotrexate, etc.). The mechanism of immunosuppressants, though not entirely clear, but is characterized by the following several aspects: ① most kinds of immunosuppressants can simultaneously inhibit cellular and humoral immunity and can be used for organ transplantation and autoimmune disease. ②Its inhibitory effect is strong for the primary immune response while the inhibitory effect against secondary response is weak. ③It can simultaneously act on normal and pathological immunity, therefore, can often lead to some complications. ④These drugs often have strong with serious adverse reactions. 2. Enzyme
Application of Nevirapine as the Non-Nucleoside Reverse Transcriptase Inhibitor
Nevirapine is a non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) that blocks RNA-dependence and the activity of DNA-dependent DNA polymerase.
Oct 15,2019 InhibitorsGefitinib: Uses in non-small cell lung cancer (NSCLC)
Gefitinib, an aniline quinazoline derivative, is an oral epidermal growth factor receptor’s (EGFR) tyrosine kinase inhibitor developed by AstraZeneca.
Oct 14,2019 InhibitorsImatinib mesylate: Tyrosine kinase inhibitor
Gefitinib, an aniline quinazoline derivative, is an oral epidermal growth factor receptor’s (EGFR) tyrosine kinase inhibitor developed by AstraZeneca.
Oct 14,2019 InhibitorsBiological activity of Inhibitor AC220
Quizartinib (AC220) is a second-generation FLT3 inhibitor for Flt3(ITD/WT) with IC50 of 1.1 nM/4.2 nM in MV4-11 and RS4;11 cells, respectively.
Oct 11,2019 InhibitorsBiological activity of PLX-4720
PLX4720 is a potent and selective inhibitor of B-RafV600E with IC50 of 13 nM in a cell-free assay, equally potent to c-Raf-1(Y340D and Y341D mutations).
Oct 11,2019 InhibitorsCP-690550 as an Inhibitor
Tofacitinib citrate is a king of drugs developed by the US pharmaceutical company Pfizer for treating rheumatoid arthritis, trade name Xeljanz.
Oct 11,2019 InhibitorsBiological activity of GSK1120212
Trametinib (GSK1120212) is a highly specific and potent MEK1/2 inhibitor with IC50 of 0.92 nM/1.8 nM in cell-free assays, no inhibition of the kinase activities of c-Raf, B-Raf, ERK1/2.
Oct 11,2019 InhibitorsBiological activity ABT-888
Veliparib (ABT-888) is a potent inhibitor of PARP1 and PARP2 with Ki of 5.2 nM and 2.9 nM in cell-free assays.
Oct 11,2019 InhibitorsAP26113 as inhibitor of cancer biomarkers
AP26113, or Brigatinib, is a novel, synthetic, orally active and potent small-molecule inhibitor of anaplastic lymphoma kinase (ALK). ALK is a receptor tyrosine kinase of the insulin receptor family.
Oct 10,2019 InhibitorsThe Applications of Epiandrosterone
Epiandrosterone is a 3beta-hydroxy steroid that is (5alpha)-androstane substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It has a role as an androgen and a human metab
Aug 20,2019 Inhibitors






